日本語 English

Mitsui Chemicals Invests in Materia Bioworks

Creating synergies in bioplastic solutions by leveraging Mitsui Chemicals’ technologies and Materia Bioworks’ AI-powered platform

2026.08.04

Mitsui Chemicals, Inc.

Mitsui Chemicals, Inc. (Headquarters: Chuo-ku, Tokyo; President and CEO: Satoshi Ichimura; hereinafter “Mitsui Chemicals”) announced today that it has made a minority investment in Materia Bioworks Inc. (Headquarters: Ontario, Canada; CEO: Hasitha de Alwis; hereinafter “Materia Bioworks”) through 321Catalyst™, its corporate venture capital (CVC) fund.

About Materia Bioworks

Materia Bioworks is a startup utilizing computational chemistry and AI to develop a platform (“MAPS”) that can efficiently design and formulate sustainable materials, such as bioplastics. By leveraging computational chemistry and AI, the company streamlines product  development using bioplastics, a process that traditionally required significant time and cost, thereby reducing development time and costs while also driving down the cost of bioplastics themselves.

Materia Bioworks’ AI-powered platform, MAPS (Material Application Prediction System) has the following functions:

※Digital twin:Technology refers to the recreation of the state of real-world equipment, products, and processes in a digital environment, enabling simulation and analysis to improve efficiency and optimize operations.

Purpose of the Investment

By utilizing their biomass materials in Materia Bioworks’ bioplastic design services, Mitsui Chemicals aims to expand its provision of bioplastic materials offering to customers globally.  Furthermore, Mitsui Chemicals will collaborate with Materia Bioworks to meet the performance and quality requirements of customers through the possible joint development of new bioplastic materials.